← SynDRA
MK-0893
SynDRA canonical compound SYN0028576 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | GCGR |
| Mechanism of action | Glucagon receptor antagonist |
All known targets
Mechanisms of action (all sources)
- Glucagon receptor antagonist
- GCGR ANTAGONIST
Cross-references
Synonyms
- Mk0893
- MK0893
- CCP2U6LWTP
- RefChem:159181
- DTXCID30419545
- C32H27Cl2N3O4
- compound 9m [PMID: 22708876]
- SCHEMBL675777
- GTPL9135
- orb1709120
- SCHEMBL29363684
- VJB82312
- BDBM50360601
- EX-A10716
- MFCD11616198
- AKOS016011529
- CS-0324
- DA-75576
- HY-50663
- MS-30504
- NS00072925
- MK-0893-005
- F83670
- T12055
- BRD-K16732600-001-01-7
- 5MV
- MK 0893
- Merck Glucagon Receptor Antagonist
- N-[(4-{(1S)-1-[3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine
- N-[4-[(1S)-1-[3-(3,5-Dichlorophenyl)-5-(6-methoxy-2-naphthalenyl)-1H-pyrazol-1-yl]ethyl]benzoyl]-beta-alanine
Look up MK-0893 in the interactive SynDRA portal →